IN2014MN01933A - - Google Patents

Info

Publication number
IN2014MN01933A
IN2014MN01933A IN1933MUN2014A IN2014MN01933A IN 2014MN01933 A IN2014MN01933 A IN 2014MN01933A IN 1933MUN2014 A IN1933MUN2014 A IN 1933MUN2014A IN 2014MN01933 A IN2014MN01933 A IN 2014MN01933A
Authority
IN
India
Prior art keywords
relates
extract
composition
present
effective amount
Prior art date
Application number
Inventor
Arvind Saklani
Parikshit Gaikwad
Aslam Burhan
Somesh Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IN2014MN01933A publication Critical patent/IN2014MN01933A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an herbal composition comprising a therapeutically effective amount of the extract of a plant belonging to Calophyllum species as an active ingredient and optionally a pharmaceutically acceptable carrier. The present invention also relates to herbal composition comprising extract obtained from the plant Calophyllum inophyllum. The invention also relates to a process for the preparation of the extract. The invention also relates to a method for the treatment of metabolic disorders using the said composition. The present invention also relates to a composition comprising a therapeutically effective amount of extract of the plants from Calophyllum species in combination with a known therapeutically active agent for use in the treatment of metabolic disorders.
IN1933MUN2014 2012-03-13 2013-03-12 IN2014MN01933A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
IN2014MN01933A true IN2014MN01933A (en) 2015-07-10

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1933MUN2014 IN2014MN01933A (en) 2012-03-13 2013-03-12

Country Status (13)

Country Link
US (1) US20150050373A1 (en)
EP (1) EP2825183A4 (en)
JP (1) JP2015509976A (en)
KR (1) KR20140138275A (en)
CN (1) CN104203258A (en)
AU (1) AU2013233930A1 (en)
CA (1) CA2866260A1 (en)
IL (1) IL234616A0 (en)
IN (1) IN2014MN01933A (en)
MX (1) MX2014010926A (en)
NZ (1) NZ630125A (en)
RU (1) RU2014140852A (en)
WO (1) WO2013136257A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3021660A1 (en) 2016-04-22 2017-10-26 Receptor Life Sciences, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EA201892396A1 (en) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. QUICKLY PRODUCTIVE PLANT MEDICINES AND BIOLOGICALLY ACTIVE ADDITIVES
US20220214367A1 (en) * 2019-04-15 2022-07-07 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
DE69739394D1 (en) * 1996-10-16 2009-06-18 Napo Pharmaceuticals Inc ENTERAL FORMULATIONS OF PROANTHOCYANIDE COMPOSITIONS AGAINST DIARRHOE
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (en) * 1999-06-18 2001-09-14 Mousny Brigitte USE OF OIL FROM PLANTS OF THE CALOPHYLLUM TYPE EXTRACTED AT AMBIENT TEMPERATURE IN COSMETIC, DIETETIC AND THERAPEUTIC COMPOSITIONS
JP2001192317A (en) * 2000-01-06 2001-07-17 Shiseido Co Ltd Matrix metalloproteinases inhibitor
JP2005272326A (en) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd Antiallergic agent, antipruritic agent and antibacterial agent
FR2886547B1 (en) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi COSMETIC, DIETETIC, PHARMACEUTICAL COMPOSITION OBTAINED FROM NON-REFINED OIL FREE OF TRANS FATTY ACIDS, PHORBOLIC ESTERS, SOLVENT-FREE EXTRACT
AU2007248183B2 (en) * 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
JP2008081440A (en) * 2006-09-27 2008-04-10 Noevir Co Ltd Aromatase activity promoter
BRPI0720452A2 (en) * 2006-12-20 2014-01-14 Novartis Ag ORGANIC COMPOUNDS
FR2915095B1 (en) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N CARE CREAM
WO2010065528A2 (en) * 2008-12-02 2010-06-10 Kreations By Kristin, L.C. Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
US20150050373A1 (en) 2015-02-19
EP2825183A1 (en) 2015-01-21
NZ630125A (en) 2017-01-27
WO2013136257A1 (en) 2013-09-19
KR20140138275A (en) 2014-12-03
AU2013233930A1 (en) 2014-09-25
IL234616A0 (en) 2014-11-30
EP2825183A4 (en) 2015-09-23
JP2015509976A (en) 2015-04-02
CN104203258A (en) 2014-12-10
MX2014010926A (en) 2015-04-10
CA2866260A1 (en) 2013-09-19
RU2014140852A (en) 2016-05-10

Similar Documents

Publication Publication Date Title
IN2014MN02269A (en)
MX2014015004A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof.
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
MX2013005549A (en) Heterocycle amines and uses thereof.
IN2012DN03312A (en)
IN2015DN01727A (en)
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2013055899A3 (en) Compositions useful in treating nephropathy and methods for preparation of same
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
IN2014DN09584A (en)
IN2014MN01933A (en)
MX2015005111A (en) Herbal composition for the prevention and treatment of tnf-î± mediated diseases.
MX2020001428A (en) Compositions of grapiprant and methods for using the same.
GB2498677A (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
EP2799082A4 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
EP2596787A4 (en) New use of hesperetin
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
BR112014004737A2 (en) Ambroxol Hydrochloride Compound Compound and Method of Preparation of Compound
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
WO2012162471A3 (en) Pachycereus plant extract and methods of use thereof
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012108746A3 (en) Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
WO2012108743A3 (en) Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract